An ex vivo method for studying inflammation in cynomolgus monkeys: Analysis of interleukin-1 receptor antagonist

Akeson, 1996, AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin-1 receptor and blocks in vivo responses to IL-1, J Biol Chem Nov/Dec, 10.1074/jbc.271.48.30517 Arend, 1991, Interleukin 1 receptor antagonist, a new member of the interleukin 1 family, J Clin Invest, 88, 1445, 10.1172/JCI115453 DeForge, 1992, Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood, Am J Pathol, 140, 1045 Dinarello, 1991, Interleukin-1 and interleukin-1 antagonist, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627 Ertel, 1995, Downregulation of proinflammatory cytokine release in whole blood from septic patients, Blood, 85, 1341, 10.1182/blood.V85.5.1341.bloodjournal8551341 Fischer, 1991, Comparison between effects of interleukin-1α administration and sublethal endotoxemia in primates, Am J Physiol, 261, R442 Granowitz, 1992, Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans, Cytokine, 4, 353, 10.1016/1043-4666(92)90078-6 Tracey, 1986, Shock and tissue injury induced by recombinant human cachetin, Science, 234, 470, 10.1126/science.3764421 Yanofsky, 1996, High affinity type I interleukin-1 receptor antagonists discovered by screening recombinant peptide libraries, 93, 7381